Chen YB, Mohty M, Zeiser R, Teshima T, et al. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial. Nat Med 2024 Jun 6. doi: 10.1038/s41591-024-03016.
PMID: 38844797